Neurocrine Bioscience buy Wells Fargo & Company
Start price
13.02.26
/
50%
€105.55
Target price
13.02.27
€147.44
Performance (%)
34.11%
Price
14:36
€141.55
Summary
This prediction is currently active. With a performance of 34.11% the BUY prediction by Wells_Fargo___Compan is a big success. This prediction currently runs until 13.02.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -2.281% | -2.281% |
| iShares Core DAX® | 2.573% | 5.333% |
| iShares Nasdaq 100 | 4.858% | 0.449% |
| iShares Nikkei 225® | 5.590% | -0.586% |
| iShares S&P 500 | 3.250% | 2.500% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by analysts at Wells Fargo & Company from $180.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€149.30
17.07.26
17.07.26
€174.84
17.07.27
17.07.27
-5.19%
14:36
14:36
